We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Boston Scientific Grows Stent Pipeline with Majority Stake in Korean Company
Boston Scientific Grows Stent Pipeline with Majority Stake in Korean Company
Boston Scientific will expand its stent manufacturing pipeline by acquiring Synergy Innovation’s majority stock holdings in M.I. Tech, a Korean company that created a family of specialty endoscopic and urologic stents that Boston Scientific has distributed in Japan since 2015.